丰倍生物上交所IPO通过上市委会议 主要以废弃油脂生产资源化产品

Core Viewpoint - Fengbei Biotechnology Co., Ltd. is set to raise 1 billion RMB through its IPO, focusing on the comprehensive utilization of waste resources, particularly waste oils, to produce biofuels and biobased materials [1] Company Overview - Fengbei Biotechnology is a high-tech enterprise in the waste resource utilization sector, primarily converting waste oils into resource products [1] - The company has developed a production chain from waste oils to biodiesel and biobased materials, leveraging its core technology and channel advantages [1] Production Capacity and Market Position - As of the end of 2024, the company has a biodiesel production capacity of 105,000 tons, ranking sixth in China's biodiesel industry [1] - The company's biodiesel production is projected to be 80,100 tons, capturing approximately 4.68% of the market share based on the estimated national biodiesel production of 1.71 million tons in 2024 [1] Financial Performance - The company reported revenues of approximately 1.709 billion RMB, 1.728 billion RMB, and 1.949 billion RMB for the years 2022, 2023, and 2024, respectively [2] - Net profits for the same years were approximately 133 million RMB, 130 million RMB, and 124 million RMB [2] - Total assets increased from approximately 937.82 million RMB in 2022 to 1.2368 billion RMB in 2024, with equity attributable to shareholders rising from approximately 513.42 million RMB to 755.79 million RMB [4] Partnerships and Collaborations - The company has established long-term collaborations with leading firms in the agricultural chemical sector, including Fengle Seed Industry, Jiuyi Co., and others [2] - In the biofuel sector, Fengbei has passed supplier assessments from major clients like Trafigura, Glencore, and Shell, indicating strong market relationships [2] Research and Development - The company allocates approximately 2.75% of its revenue to research and development, reflecting its commitment to innovation in the waste resource utilization field [4]